188
Views
7
CrossRef citations to date
0
Altmetric
Original Investigation

Ventricular volume, white matter alterations and outcome of major depression and their relationship to endocrine parameters – A pilot study

ORCID Icon, , , , , ORCID Icon, , & show all
Pages 104-118 | Received 03 Jul 2019, Accepted 13 Apr 2020, Published online: 15 May 2020

References

  • Abe O, Yamasue H, Kasai K, Yamada H, Aoki S, Inoue H, Takei K, Suga M, Matsuo K, Kato T, et al. 2010. Voxel-based analyses of gray/white matter volume and diffusion tensor data in major depression. Psychiatry Res. 181:64–70.
  • Andrews LE, Liu GT, Ko MW. 2014. Idiopathic intracranial hypertension and obesity. Horm Res Paediatr. 81:217–225.
  • Antonijevic IA, Murck H, Frieboes RM, Horn R, Brabant G, Steiger A. 1998. Elevated nocturnal profiles of serum leptin in patients with depression. J PsychiatrRes. 32:403–410.
  • Apostolopoulou K, Kunzel HE, Gerum S, Merkle K, Schulz S, Fischer E, Pallauf A, Brand V, Bidlingmaier M, Endres S, et al. 2014. Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: a cross-sectional study. World J Biol Psychiatry. 15:26–35.
  • Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F. 2000. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry. 47:305–313.
  • Bollettini I, Poletti S, Locatelli C, Vai B, Smeraldi E, Colombo C, Benedetti F. 2015. Disruption of white matter integrity marks poor antidepressant response in bipolar disorder. J Affect Disord. 174:233–240.
  • Büttner M, Jezova D, Greene B, Konrad C, Kircher T, Murck H. 2015. Target-based biomarker selection - mineralocorticoid receptor-related biomarkers and treatment outcome in major depression. J Psychiatr Res. 66-67:24–37.
  • Cardoner N, Pujol J, Vallejo J, Urretavizcaya M, Deus J, Lopez-Sala A, Benlloch L, Menchon JM. 2003. Enlargement of brain cerebrospinal fluid spaces as a predictor of poor clinical outcome in melancholia. J Clin Psychiatry. 64:691–697.
  • Carroll BJ, Curtis GC. 1976. Neuroendocrine identification of depressed patients. Aust N Z J Psychiatry. 10:13–20.
  • Chen G, Hu X, Li L, Huang X, Lui S, Kuang W, Ai H, Bi F, Gu Z, Gong Q. 2016. Disorganization of white matter architecture in major depressive disorder: a meta-analysis of diffusion tensor imaging with tract-based spatial statistics. Sci Rep. 6:21825.
  • Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP, Myers RM, Bunney WE Jr, Akil H, Watson SJ, et al. 2005. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A. 102:15653–15658.
  • Cole J, Chaddock CA, Farmer AE, Aitchison KJ, Simmons A, McGuffin P, Fu CH. 2012. White matter abnormalities and illness severity in major depressive disorder. Br J Psychiatry. 201:33–39.
  • Coppen A. 1967. The biochemistry of affective disorders. Br J Psychiatry. 113:1237–1264.
  • De Bellis MD, Hooper SR. 2012. Neural substrates for processing task-irrelevant emotional distracters in maltreated adolescents with depressive disorders: a pilot study. J Traum Stress. 25:198–202.
  • De Bellis MD, Zisk A. 2014. The biological effects of childhood trauma. Child Adolesc Psychiatr Clin N Am. 23:185–222. vii.
  • de Diego-Adeliño J, Pires P, Gómez-Ansón B, Serra-Blasco M, Vives-Gilabert Y, Puigdemont D, Martín-Blanco A, Álvarez E, Pérez V, Portella MJ. 2014. Microstructural white-matter abnormalities associated with treatment resistance, severity and duration of illness in major depression. Psychol Med. 44:1171–1182.
  • de Kloet ER, Joels M. 2017. Brain mineralocorticoid receptor function in control of salt balance and stress-adaptation. Physiol Behav. 178:13–20.
  • Dillon DG, Gonenc A, Belleau E, Pizzagalli DA. 2018. Depression is associated with dimensional and categorical effects on white matter pathways. Depress Anxiety. 35:440–447.
  • Drevets WC. 1999. Prefrontal cortical-amygdalar metabolism in major depression. Annals NY Acad Sci. 877:614–637.
  • Drevets WC. 2003. Neuroimaging abnormalities in the amygdala in mood disorders. Ann N Y Acad Sci. 985:420–444.
  • Drevets WC, Ongur D, Price JL. 1998. Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Mol Psychiatry. 3:220–226.
  • Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A, Hauner H, McCann SM, Scherbaum WA, Bornstein SR. 2003. Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci U S A. 100:14211–14216.
  • Emanuele E, Geroldi D, Minoretti P, Coen E, Politi P. 2005. Increased plasma aldosterone in patients with clinical depression. Arch Med Res. 36:544–548.
  • Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, et al. 2002. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 33:341–355.
  • Franklin M, Bermudez I, Hlavacova N, Babic S, Murck H, Schmuckermair C, Singewald N, Gaburro S, Jezova D. 2012a. Aldosterone increases earlier than corticosterone in new animal models of depression: is this an early marker?. J Psychiatr Res. 46:1394–1397.
  • Franklin M, Bermudez I, Murck H, Singewald N, Gaburro S. 2012b. Sub-chronic dietary tryptophan depletion–an animal model of depression with improved face and good construct validity. J Psychiatr Res. 46:239–247.
  • Frodl T, Meisenzahl EM, Zetzsche T, Born C, Jager M, Groll C, Bottlender R, Leinsinger G, Moller HJ. 2003. Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects. Biol Psychiatry. 53:338–344.
  • Frodl T, Meisenzahl E, Zetzsche T, Bottlender R, Born C, Groll C, Jager M, Leinsinger G, Hahn K, Moller HJ. 2002. Enlargement of the amygdala in patients with a first episode of major depression. Biol Psychiatry. 51:708–714.
  • Geerling JC, Loewy AD. 2006a. Aldosterone-sensitive neurons in the nucleus of the solitary tract: bidirectional connections with the central nucleus of the amygdala. J Comp Neurol. 497:646–657. eng.
  • Geerling JC, Loewy AD. 2006b. Aldosterone-sensitive neurons in the nucleus of the solitary tract: efferent projections. J Comp Neurol. 497:223–250.
  • Gideon A, Sauter C, Fieres J, Berger T, Renner B, Wirtz PH. 2020. Kinetics and interrelations of the renin aldosterone response to acute psychosocial stress: a neglected stress system. J Clin Endocrinol Metab. 105:dgz190.
  • Guy W. 1976. Clinical Global Impressions CGI. In: Guy W, editor. ECDEU assessment manual for psychopharmacology, revised. Rockville (MD): U.S. Department of Health, Education, and Welfare.
  • Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. 2015. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 116:991–1006.
  • Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiat. 23:56–62.
  • Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC. 2007. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 64:193–200.
  • Hausdorff JM, Peng CK, Goldberger AL, Stoll AL. 2004. Gait unsteadiness and fall risk in two affective disorders: a preliminary study. BMC Psychiatry. 4:39.
  • Hellstrom T, Kaufmann T, Andelic N, Soberg HL, Sigurdardottir S, Helseth E, Andreassen OA, Westlye LT. 2017. Predicting outcome 12 months after mild traumatic brain injury in patients admitted to a neurosurgery service. Front Neurol. 8:125.
  • Henckens MJ, van der Marel K, van der Toorn A, Pillai AG, Fernandez G, Dijkhuizen RM, Joels M. 2015. Stress-induced alterations in large-scale functional networks of the rodent brain. Neuroimage. 105:312–322.
  • Hlavacova N, Jezova D. 2008. Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior. Horm Behav. 54:90–97.
  • Hlavacova N, Kerlik J, Radikova Z, Izakova L, Jezova D. 2013. Measurement of salivary aldosterone: validation by low-dose ACTH test and gender differences. Endocr Regul. 47:201–204.
  • Hlavacova N, Wes PD, Ondrejcakova M, Flynn ME, Poundstone PK, Babic S, Murck H, Jezova D. 2012. Subchronic treatment with aldosterone induces depression-like behaviours and gene expression changes relevant to major depressive disorder. Int J Neuropsychopharm. 15:247–265. eng.
  • Israelsson H, Carlberg B, Wikkelso C, Laurell K, Kahlon B, Leijon G, Eklund A, Malm J. 2017. Vascular risk factors in INPH: a prospective case-control study (the INPH-CRasH study). Neurology. 88:577–585.
  • Jeon JH, Kim KY, Kim JH, Baek A, Cho H, Lee YH, Kim JW, Kim D, Han SH, Lim JS, et al. 2008. A novel adipokine CTRP1 stimulates aldosterone production. FASEB J. 22:1502–1511.
  • Kagerbauer SM, Martin J, Schuster T, Blobner M, Kochs EF, Landgraf R. 2013. Plasma oxytocin and vasopressin do not predict neuropeptide concentrations in human cerebrospinal fluid. J Neuroendocrinol. 25:668–673.
  • Kalyan-Masih P, Vega-Torres JD, Miles C, Haddad E, Rainsbury S, Baghchechi M, Obenaus A, Figueroa JD. 2016. Western high-fat diet consumption during adolescence increases susceptibility to traumatic stress while selectively disrupting hippocampal and ventricular volumes. eNeuro. 3:ENEURO.0125-16.2016.
  • Kang K, Choi W, Yoon U, Lee JM, Lee HW. 2016. Abnormal white matter integrity in elderly patients with idiopathic normal-pressure hydrocephalus: a tract-based spatial statistics study. Eur Neurol. 75:96–103.
  • Kanno S, Saito M, Kashinoura T, Nishio Y, Iizuka O, Kikuchi H, Takagi M, Iwasaki M, Takahashi S, Mori E. 2017. A change in brain white matter after shunt surgery in idiopathic normal pressure hydrocephalus: a tract-based spatial statistics study. Fluids Barriers Cns. 14:1.
  • Kaur C, Rathnasamy G, Ling EA. 2016. The choroid plexus in healthy and diseased brain. J Neuropathol Exp Neurol. 75:198–213.
  • Keong NC, Pena A, Price SJ, Czosnyka M, Czosnyka Z, DeVito EE, Housden CR, Sahakian BJ, Pickard JD. 2017. Diffusion tensor imaging profiles reveal specific neural tract distortion in normal pressure hydrocephalus. PLoS One. 12:e0181624.
  • Khan MU, Khalid H, Salpietro V, Weber KT. 2013. Idiopathic intracranial hypertension associated with either primary or secondary aldosteronism. Am J Med Sci. 346:194–198.
  • Kircher T, Wohr M, Nenadic I, Schwarting R, Schratt G, Alferink J, Culmsee C, Garn H, Hahn T, Muller-Myhsok B, et al. 2019. Neurobiology of the major psychoses: a translational perspective on brain structure and function-the FOR2107 consortium. Eur Arch Psychiatry Clin Neurosci. 269:949–962.
  • Kloiber S, Ising M, Reppermund S, Horstmann S, Dose T, Majer M, Zihl J, Pfister H, Unschuld PG, Holsboer F, et al. 2007. Overweight and obesity affect treatment response in major depression. Biol Psychiatry. 62:321–326.
  • Kondziella D, Ludemann W, Brinker T, Sletvold O, Sonnewald U. 2002. Alterations in brain metabolism, CNS morphology and CSF dynamics in adult rats with kaolin-induced hydrocephalus. Brain Res. 927:35–41.
  • Korgaonkar MS, Grieve SM, Koslow SH, Gabrieli JD, Gordon E, Williams LM. 2011. Loss of white matter integrity in major depressive disorder: evidence using tract-based spatial statistical analysis of diffusion tensor imaging. Hum Brain Mapp. 32:2161–2171.
  • Kunzel HE, Apostolopoulou K, Pallauf A, Gerum S, Merkle K, Schulz S, Fischer E, Brand V, Bidlingmaier M, Endres S, et al. 2012. Quality of life in patients with primary aldosteronism: Gender differences in untreated and long-term treated patients and associations with treatment and aldosterone. J Psychiatr Res. 46:1650–1654.
  • Lamers F, de Jonge P, Nolen WA, Smit JH, Zitman FG, Beekman AT, Penninx BW. 2010. Identifying depressive subtypes in a large cohort study: results from the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry. 71:1582–1589.
  • Lamers F, Vogelzangs N, Merikangas KR, de Jonge P, Beekman AT, Penninx BW. 2013. Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry. 18:692–699.
  • Lauer CJ, Krieg JC. 1998. Slow-wave sleep and ventricular size: a comparative study in schizophrenia and major depression. Biol Psychiatry. 44:121–128.
  • Lauer CJ, Wiegand M, Krieg JC. 1992. All-night electroencephalographic sleep and cranial computed tomography in depression. A study of unipolar and bipolar patients. Eur Arch Psychiatry Clin Nuerosci. 242:59–68.
  • Lavagnino L, Amianto F, Mwangi B, D'Agata F, Spalatro A, Zunta-Soares GB, Abbate Daga G, Mortara P, Fassino S, Soares JC. 2015. Identifying neuroanatomical signatures of anorexia nervosa: a multivariate machine learning approach. Psychol Med. 45:2805–2812.
  • Leuchter AF, Cook IA, Uijtdehaage SH, Dunkin J, Lufkin RB, Anderson-Hanley C, Abrams M, Rosenberg-Thompson S, O’Hara R, Simon SL. 1997. Brain structure and function and the outcomes of treatment for depression. J Clin Psychiatry. 58Suppl:22–31.
  • LeWinn KZ, Connolly CG, Wu J, Drahos M, Hoeft F, Ho TC, Simmons AN, Yang TT. 2014. White matter correlates of adolescent depression: structural evidence for frontolimbic disconnectivity. J Am Acad Child Adolesc Psychiatry. 53:899–909, 909.e1–7.
  • Liao Y, Huang X, Wu Q, Yang C, Kuang W, Du M, Lui S, Yue Q, Chan RC, Kemp GJ, et al. 2013. Is depression a disconnection syndrome? Meta-analysis of diffusion tensor imaging studies in patients with MDD. J Psychiatry Neurosci. 38:49–56.
  • Lyden H, Espinoza RT, Pirnia T, Clark K, Joshi SH, Leaver AM, Woods RP, Narr KL. 2014. Electroconvulsive therapy mediates neuroplasticity of white matter microstructure in major depression. Transl Psychiatry. 4:e380.
  • Markey KA, Uldall M, Botfield H, Cato LD, Miah MA, Hassan-Smith G, Jensen RH, Gonzalez AM, Sinclair AJ. 2016. Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases. J Pain Res. 9:223–232.
  • Melo TM, Haberg AK, Risa O, Kondziella D, Henry PG, Sonnewald U. 2011. Tricarboxylic acid cycle activity measured by 13C magnetic resonance spectroscopy in rats subjected to the kaolin model of obstructed hydrocephalus. Neurochem Res. 36:1801–1808.
  • Murck H. 2013. Ketamine, magnesium and major depression–from pharmacology to pathophysiology and back. J Psychiatr Res. 47:955–965.
  • Murck H, Braunisch MC, Konrad C, Jezova D, Kircher T. 2019. Markers of mineralocorticoid receptor function: changes over time and relationship to response in patients with major depression. Int Clin Psychopharmacol. 34:18–26.
  • Murck H, Buttner M, Kircher T, Konrad C. 2014. Genetic, molecular and clinical determinants for the involvement of aldosterone and its receptors in major depression. Nephron Physiol. 128:17–25.
  • Murck H, Held K, Ziegenbein M, Kunzel H, Koch K, Steiger A. 2003. The renin-angiotensin-aldosterone system in patients with depression compared to controls–a sleep endocrine study. BMC Psychiatry. 3:15.
  • Murck H, Schubert MI, Schmid D, Schussler P, Steiger A, Auer DP. 2009. The glutamatergic system and its relation to the clinical effect of therapeutic-sleep deprivation in depression – an MR spectroscopy study. J Psychiatr Res. 43:175–180.
  • Murck H, Schussler P, Steiger A. 2012. Renin-angiotensin-aldosterone system: the forgotten stress hormone system: relationship to depression and sleep. Pharmacopsychiatry. 45:83–95.
  • Murck H. 2017. Aldosterone action on brain and behavior. In: Pfaff DW, Joëls M, editors. Hormones, brain, and behavior. 3rd ed. Oxford: Academic Press; p. 159–179.
  • Nagase M, Yoshida S, Shibata S, Nagase T, Gotoda T, Ando K, Fujita T. 2006. Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. JASN. 17:3438–3446.
  • Nowacki J, Wingenfeld K, Kaczmarczyk M, Chae WR, Salchow P, Abu-Tir I, Piber D, Hellmann-Regen J, Otte C. 2020. Steroid hormone secretion after stimulation of mineralocorticoid and NMDA receptors and cardiovascular risk in patients with depression. Transl Psychiatry. 10:109.
  • Paleacu D, Shutzman A, Giladi N, Herman T, Simon ES, Hausdorff JM. 2007. Effects of pharmacological therapy on gait and cognitive function in depressed patients. Clin Neuropharmacol. 30:63–71.
  • Repple J, Opel N, Meinert S, Redlich R, Hahn T, Winter NR, Kaehler C, Emden D, Leenings R, Grotegerd D, et al. 2018. Elevated body-mass index is associated with reduced white matter integrity in two large independent cohorts. Psychoneuroendocrinology. 91:179–185.
  • Salpietro V, Ruggieri M. 2014. Pseudotumor cerebri pathophysiology: the likely role of aldosterone. Headache. 54:1229–1229.
  • Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, Krystal JH, Mason GF. 2004. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry. 61:705–713.
  • Sapolsky RM. 2000. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry. 48:755–765.
  • Schildkraut JJ. 1965. The catecholamine hypothesis of affective disorders: a review of supporting evidence. AJP. 122:509–522.
  • Schlegel S, Maier W, Philipp M, Aldenhoff JB, Heuser I, Kretzschmar K, Benkert O. 1989. Computed tomography in depression: association between ventricular size and psychopathology. Psychiatry Res. 29:221–230.
  • Schneider U, Malmadier A, Dengler R, Sollmann WP, Emrich HM. 1996. Mood cycles associated with normal pressure hydrocephalus. Am J Psychiatry. 153:1366–1367.
  • Segeda V, Izakova L, Hlavacova N, Bednarova A, Jezova D. 2017. Aldosterone concentrations in saliva reflect the duration and severity of depressive episode in a sex dependent manner. J Psychiatr Res. 91:164–168.
  • Selye H. 1955a. Stress and disease. Science. 122:625–631.
  • Selye H. 1955b. Stress and disease. Laryngoscope. 65:500–514.
  • Sheldon CA, Kwon YJ, Liu GT, McCormack SE. 2015. An integrated mechanism of pediatric pseudotumor cerebri syndrome: evidence of bioenergetic and hormonal regulation of cerebrospinal fluid dynamics. Pediatr Res. 77:282–289.
  • Sonino N, Fallo F, Fava GA. 2006. Psychological aspects of primary aldosteronism. Psychother Psychosom. 75:327–330.
  • Sosvorova L, Hill M, Mohapl M, Vitku J, Hampl R. 2015. Steroid hormones in prediction of normal pressure hydrocephalus. J Steroid Biochem Mol Biol. 152:124–132.
  • Steers WD, Lee KS. 2001. Depression and incontinence. World J Urol. 19:351–357.
  • Stratmann M, Konrad C, Kugel H, Krug A, Schoning S, Ohrmann P, Uhlmann C, Postert C, Suslow T, Heindel W, et al. 2014. Insular and hippocampal gray matter volume reductions in patients with major depressive disorder. PLoS One. 9:e102692.
  • Sugerman HJ. 2001. Effects of increased intra-abdominal pressure in severe obesity. Surg Clin North Am. 81:1063–1075.
  • Thayer JF, Ahs F, Fredrikson M, Sollers JJ, 3rd, Wager TD. 2012. A meta-analysis of heart rate variability and neuroimaging studies: implications for heart rate variability as a marker of stress and health. Neurosci Biobehav Rev. 36:747–756.
  • Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, et al.; STAR*D Study Team. 2006. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. AJP. 163:28–40.
  • Trullas R, Skolnick P. 1990. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol. 185:1–10.
  • Vasavada MM, Leaver AM, Espinoza RT, Joshi SH, Njau SN, Woods RP, Narr KL. 2016. Structural connectivity and response to ketamine therapy in major depression: a preliminary study. J Affect Disord. 190:836–841.
  • Vrijens D, Drossaerts J, van Koeveringe G, Van Kerrebroeck P, van Os J, Leue C. 2015. Affective symptoms and the overactive bladder – a systematic review. J Psychosom Res. 78:95–108.
  • Walther S, Hugli S, Hofle O, Federspiel A, Horn H, Bracht T, Wiest R, Strik W, Muller TJ. 2012. Frontal white matter integrity is related to psychomotor retardation in major depression. Neurobiol Dis. 47:13–19.
  • Weber KT. 2003. Aldosteronism revisited: perspectives on less well-recognized actions of aldosterone. J Lab Clin Med. 142:71–82.
  • Wise T, Radua J, Nortje G, Cleare AJ, Young AH, Arnone D. 2016. Voxel-based meta-analytical evidence of structural disconnectivity in major depression and bipolar disorder. Biol Psychiatry. 79:293–302.
  • Wise T, Radua J, Via E, Cardoner N, Abe O, Adams TM, Amico F, Cheng Y, Cole JH, de Azevedo Marques Perico C, et al. 2017. Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: evidence from voxel-based meta-analysis. Mol Psychiatry. 22:1455–1463.
  • Yoo HJ, Thayer JF, Greening S, Lee TH, Ponzio A, Min J, Sakaki M, Nga L, Mather M, Koenig J, 2018. Brain structural concomitants of resting state heart rate variability in the young and old: evidence from two independent samples. Brain Struct Funct. 223:727–737.
  • Zarate C, Duman RS, Liu G, Sartori S, Quiroz J, Murck H, 2013. New paradigms for treatment-resistant depression. Ann NY Acad Sci. 1292:21–31.
  • Zavorotnyy M, Zöllner R, Schulte-Güstenberg LR, Wulff L, Schöning S, Dannlowski U, Kugel H, Arolt V, Konrad C, 2018. Low left amygdala volume is associated with a longer duration of unipolar depression. J Neural Transm. 125:229–238.
  • Zhou G, Hotta J, Lehtinen MK, Forss N, Hari R, 2015. Enlargement of choroid plexus in complex regional pain syndrome. Sci Rep. 5:14329.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.